Antihistamine Options for a 20-Month-Old Child
For a 20-month-old child requiring antihistamine therapy, cetirizine 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a typical 10 kg child) is the recommended oral antihistamine, as it is one of only two antihistamines with documented safety data and FDA approval for children under 2 years of age. 1, 2
FDA-Approved Options for This Age Group
- Cetirizine is the primary choice for infants 6-11 months and toddlers up to 2 years, with a proven safety profile in a randomized, double-blind, placebo-controlled study specifically conducted in infants 6-11 months of age 2
- The recommended dose is 0.25 mg/kg twice daily, which translates to approximately 2.5 mg twice daily for a typical 10 kg toddler 1
- Cetirizine and loratadine are the only two antihistamines with FDA approval for children under 5 years of age 1
Alternative Second-Generation Antihistamine
- Loratadine can be considered as an alternative, though it is typically dosed at 5 mg once daily for children aged 2-5 years 1, 3
- For a 20-month-old (just under 2 years), loratadine dosing would require physician consultation, as most approval extends down to age 2 years 1
Critical Safety Warnings: What to Avoid
- Never prescribe first-generation antihistamines (diphenhydramine, hydroxyzine) for routine allergic symptoms in children under 6 years due to significant safety concerns 1, 3
- Between 1969-2006, there were 69 fatalities associated with antihistamines in children under 6 years, with 41 deaths occurring in children under 2 years, and diphenhydramine was responsible for 33 of these deaths 1, 3
- The FDA and American Academy of Pediatrics explicitly recommend against using OTC cough and cold medications containing first-generation antihistamines in children below 6 years of age 1, 3
- Intranasal antihistamines (azelastine, olopatadine) are only approved for children 12 years and older and should not be used in this age group 4, 1
Preferred First-Line Treatment Alternative
- Intranasal corticosteroids are actually the most effective medication class for controlling all symptoms of allergic rhinitis in children under 2 years, with high-quality evidence supporting their use 1
- When given in recommended doses, intranasal corticosteroids are not associated with clinically significant systemic side effects 1
- Consider intranasal corticosteroids as first-line therapy, with cetirizine as second-line or adjunctive treatment 1
Practical Administration Considerations
- Liquid formulations are strongly preferred in young children for easier administration and better absorption 3
- Monitor for possible sedation with higher-than-usual doses of cetirizine, though this is uncommon at recommended dosing 1
- Second-generation antihistamines like cetirizine have been shown to be well-tolerated with excellent safety profiles in young children 1, 5, 6
Common Pitfall to Avoid
- Do not use antihistamines "to make a child sleepy"—this is explicitly contraindicated per FDA labeling 3
- Avoid OTC cough and cold combination products in children under 6 years due to overdose risk 3
- Oral decongestants (pseudoephedrine, phenylephrine) should be used with extreme caution in infants and young children, as use has been associated with agitated psychosis, ataxia, hallucinations, and even death 4